EN DE
Watch Morixe Hermanos SACI for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Morixe Hermanos SACI (MORI) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Morixe Hermanos SACI stock ARS 10.69, price ARS 19.80, that is 46.0% below the price, quality 16 out of 100. Rating: strongly overvalued. Calculated from audited financials with 9 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Consumer Defensive AR · ISIN ARP698141040

MH Morixe Hermanos SACI logo Thin data Nov 7, 2026

Morixe Hermanos SACI

MORI · BA
Very expensive, weak quality

Our calculation puts a fair price 46% below what the stock costs today.

Low debt
Mixed Growth (revenue 5y +70.1 %/yr in ARS)
Loss over the last twelve months · -2.0% net margin (TTM) · fiscal year 2026 0.8%
Mixed vs. peers (4/10)
Profit last quarter 75% below a year ago.
Fair value 10.69 ARS · Strongly overvalued
Quality 16/100
Negative free cash flow
Narrow moat 22/100
Thin data
⟳ Cyclical⚠ Dilution
Watch Morixe Hermanos SACI for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

413.00 ARS 11.20 ARS Fair Value 10.69 ARS Jul 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

60‑month range 11.20 ARS – 413.00 ARS · fair‑value band 9.49 ARS – 12.68 ARS · the 19.80 ARS price screens above the 10.69 ARS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow Morixe Hermanos SACI in your weekly email

Every Wednesday you see whether Morixe Hermanos SACI is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Morixe Hermanos S.A.C.I. manufactures, markets, and sells food products in Argentina and internationally.

Show moreShow less

It offers oils and dressings, green olives, oatmeal and avena, cake mix, conservas, corn and wheat flour, breadcrumbs, pasta, and mashed potatoes, as well as olives, tomato pulp, dressings, and fruit juices; and oat-derived products. It also exports frozen organic fruits and seeds.

The company was formerly known as Francisco Morixe e Hijos Sociedad Colectiva and changed its name to Morixe Hermanos S.A.C.I. in 1914. Morixe Hermanos S.A.C.I. was founded in 1901 and is based in Buenos Aires, Argentina.

Morixe Hermanos S.A.C.I. operates as a subsidiary of Sociedad Comercial del Plata S.A.

Stock analysis

Morixe Hermanos SACI (MORI) currently trades at 19.80 ARS, while our model-based Fair Value estimate is 10.69 ARS, 46% below the price, so the stock looks overvalued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of 20.78 ARS per share, and 3 of the 9 models we run sit above the 19.80 ARS price.

Bear case: the Multiples group reads lowest at 9.53 ARS, and 6 of the 9 models stay below the price. Data coverage for this calculation is low.

Scenario range: 9.49 ARS (bear) to 12.68 ARS (bull), the price of 19.80 ARS sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 16/100 (below-average quality), in the Consumer Defensive sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Morixe Hermanos SACI reported revenue of 121B ARS in FY2026 versus 8.5B ARS in FY2021, a compound +70.1%/yr. Reported net income was 1.0B ARS in FY2026, compounding +41.9%/yr from FY2021. FY2021 was a trough year, so the rate overstates the trend.

Key figures

Market cap 44.6B ARS (≈ $28.9M) Micro · P/S ratio 0.34 · EPS (TTM) −5.67 ARS · Net margin 0.8% · Return on equity −3.4% · Return on assets (EBIT) 12.5% (5-year average) · Operating margin −0.8% · Revenue (TTM) 134B ARS.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (medium confidence).

What moves the price

The share trades about 62% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at −46%, MORI screens richer than that median.

Fair Value models

Bear 9.49 ARS Fair Value 10.69 ARS Bull 12.68 ARS
Price 19.80 ARS · Downside -46.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income 11.17 ARS 12.58 ARS 14.92 ARS 68
Growth-Adj P/E 14.55 ARS 20.78 ARS 27.02 ARS 65
P/E Multiple 7.15 ARS 9.53 ARS 11.92 ARS 63
All 9 models by family
Earnings-Based
Graham-Dodd 3.09 ARS 21.53 ARS 30.21 ARS 61
Lynch FV 11.12 ARS 15.89 ARS 20.66 ARS 59
PEG = 1.0 11.12 ARS 15.89 ARS 20.66 ARS 55
Multiples
P/E Multiple 7.15 ARS 9.53 ARS 11.92 ARS 63
P/S Multiple 5.79 ARS 7.72 ARS 9.65 ARS 58
P/B Multiple 105.54 ARS 140.72 ARS 175.90 ARS 55
Asset-Based
NCAV (Graham) 12.79 ARS 17.14 ARS 25.59 ARS 54
Economic Profit
Residual Income 11.17 ARS 12.58 ARS 14.92 ARS 68
Growth Earnings
Growth-Adj P/E 14.55 ARS 20.78 ARS 27.02 ARS 65

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 16/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 30
How much profit the company makes from its sales and capital
Quality Growth 4
Are margins and returns getting better?
Cashflow 8
Do the profits arrive as real cash?
Financial strength 47
Debt, balance sheet and risk of trouble
Investment 29
Does it invest with discipline instead of growing at any price?
Low Volatility 79
How calm the share price moves, does not count
Price momentum 11
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 0
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 44/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−11.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+31.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+70.1%
Start year 2021 (pandemic). Over 10 years: +100.3% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+100.3%
What shareholders gained per year (last 5 years), in ARS ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in ARS: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+6.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+6.8%
Dividend (yield on the price)0.0%
Profit margin 2019 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.7% → −5%

MORI screens overvalued: fair value 46% below the price. Compare with Muyuan Foods Group →

Compare Morixe Hermanos SACI with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Farm Products · 291 stocks

Beats the industry median on 4/9 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 16 · Bottom 25%
Fair Value upside −46.0% · Bottom 25%
Profitability
Return on assets 0.7% · Below median
Net margin (12 months) −2.0% · Below median
Operating margin (12 months) −0.8% · Below median
Growth and dividend
Revenue growth (quarter YoY) 11.2% · Above median
Balance sheet
Debt / equity 0.07× · Below median

Valuation Multiplesvs Farm Products median · lower = cheaper

P/B 0.68× · Cheapest 25%
P/S (12 months) 0.33× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 27
FUTURE (revenue growth)56 · sector 15
PAST (return on equity)0 · sector 17
HEALTH (low debt)96 · sector 94
DIVIDEND (yield)0 · sector 41

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Farm Products stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Charoen Pokphand Foods Public Company CPF 20.10 THB 40.78 THB +103% vs MORI
Mowi ASA MOWI kr 218.00 kr 273.41 +25% vs MORI
Tyson Foods, Inc TSN $59.68 $73.24 +23% vs MORI
Muyuan Foods Group 002714 ¥44.40 ¥53.02 +19% vs MORI
United Plantations Berhad 2089 30.38 MYR 33.42 MYR +10% vs MORI
Archer-Daniels-Midland Company ADM $69.97 $61.55 −12% vs MORI
Wens Foodstuff Group 300498 ¥16.82 ¥12.08 −28% vs MORI
Fujian Wanchen Food Group 300972 ¥129.60 ¥88.62 −32% vs MORI
Bunge Global SA BG $99.10 $56.81 −43% vs MORI
SalMar ASA SALM kr 572.50 kr 260.28 −55% vs MORI

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Morixe Hermanos SACI: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Morixe Hermanos SACI Fair Value". https://www.fairvalue-calculator.com/stock/MORI

Frequently asked questions

Is Morixe Hermanos SACI (MORI) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of 10.69 ARS versus a price of 19.80 ARS, about 46% lower (overvalued).
What is the fair value of MORI?
Our model-based fair value for Morixe Hermanos SACI is 10.69 ARS (as of Nov 7, 2026), built from audited fundamentals. The current price: 19.80 ARS.
What is the quality score of MORI?
Morixe Hermanos SACI has a Quality Score of 16/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Morixe Hermanos SACI (MORI)?
Our model-based price target is the fair value of 10.69 ARS (as of Nov 7, 2026) from 9 valuation models. Cautious scenario 9.49 ARS, optimistic scenario 12.68 ARS. It is a calculation from audited fundamentals, not an analyst target.
What is the Morixe Hermanos SACI stock forecast for 2026?
Our models put fair value at 10.69 ARS, about 46% lower versus a price of 19.80 ARS (overvalued). Cautious scenario 9.49 ARS, optimistic scenario 12.68 ARS. The calculation is refreshed regularly with new filings.
What is the revenue of Morixe Hermanos SACI (MORI)?
Morixe Hermanos SACI reported trailing-twelve-month revenue of about 134B ARS (latest available figure, as of Nov 7, 2026).
What is the intrinsic value of Morixe Hermanos SACI (MORI)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Morixe Hermanos SACI it is 10.69 ARS per share (as of Nov 7, 2026), against a price of 19.80 ARS. It is the blended result of 9 valuation models in 5 families (Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings).
Is Morixe Hermanos SACI stock overvalued or undervalued in 2026?
As of Nov 7, 2026, MORI trades above its calculated fair value: price 19.80 ARS, fair value 10.69 ARS, a gap of about −46% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MORI?
No. The price is what the market pays today (19.80 ARS); the fair value is what the company's own numbers justify (10.69 ARS). For Morixe Hermanos SACI the two are 9.11 ARS per share apart. That gap is exactly why we show both numbers side by side.
How much is Morixe Hermanos SACI worth?
The market values Morixe Hermanos SACI at about 44.6B ARS (market capitalisation, as of Nov 7, 2026). Per share that is 19.80 ARS; our models calculate a fair value of 10.69 ARS per share.
What do the bullish and bearish scenarios say about MORI?
Our models span a range for Morixe Hermanos SACI: cautious scenario 9.49 ARS, base 10.69 ARS, optimistic 12.68 ARS per share (as of Nov 7, 2026, price 19.80 ARS). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Morixe Hermanos SACI (MORI)?
Balance-sheet figures for Morixe Hermanos SACI (as of Nov 7, 2026): return on equity −3.4%, debt of 0.07 per unit of equity. They feed the Quality Score of 16/100, which measures business quality independently of the share price.
How far is MORI from its 52-week high?
Morixe Hermanos SACI trades at 19.80 ARS, about 62% below its 52-week high of 51.80 ARS and 1% above the low of 19.60 ARS (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 10.69 ARS is for.
Which stocks are comparable to Morixe Hermanos SACI?
From the same area (Consumer Defensive) we also value Muyuan Foods Group, Archer-Daniels-Midland Company, Tyson Foods, Inc, Bunge Global SA, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Morixe Hermanos SACI stock attractive at the current price?
The data as of Nov 7, 2026: price 19.80 ARS, calculated fair value 10.69 ARS (−46%), Quality Score 16/100, from 9 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MORI calculated?
We run Morixe Hermanos SACI through 9 models from 5 families: Earnings-Based, Multiples, Asset-Based, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 10.69 ARS builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Morixe Hermanos SACI itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Morixe Hermanos SACI (MORI)?
The closing price on Nov 6, 2026 was 19.80 ARS. Our model-based fair value is 10.69 ARS, about 46% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Morixe Hermanos SACI right now?
The price sits above even our optimistic bull case (12.68 ARS). The favourable scenario is already priced in. Weak quality (16/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Morixe Hermanos SACI

How large is the market capitalisation of Morixe Hermanos SACI (MORI)?
The market capitalisation of Morixe Hermanos SACI is 44.6B ARS (≈ $28.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Morixe Hermanos SACI (MORI)?
The price-to-sales ratio of Morixe Hermanos SACI is 0.34 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Morixe Hermanos SACI (MORI)?
Earnings per share at Morixe Hermanos SACI are −5.67 ARS. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Morixe Hermanos SACI (MORI)?
The net margin of Morixe Hermanos SACI is 0.8% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Morixe Hermanos SACI (MORI)?
The return on equity (ROE) of Morixe Hermanos SACI is −3.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Morixe Hermanos SACI (MORI)?
On an EBIT basis the return on assets of Morixe Hermanos SACI is 12.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Morixe Hermanos SACI (MORI)?
The operating margin of Morixe Hermanos SACI is −0.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Morixe Hermanos SACI (MORI)?
Revenue at Morixe Hermanos SACI is growing +11.2% versus a year earlier (3y avg +113%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Morixe Hermanos SACI (MORI)?
Earnings per share at Morixe Hermanos SACI are growing −74.5% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Morixe Hermanos SACI (MORI) generate?
The free cash flow of Morixe Hermanos SACI is −5.6B ARS (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Morixe Hermanos SACI (MORI) carry?
The net debt of Morixe Hermanos SACI is 15.4B ARS (fiscal year 2026). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Morixe Hermanos SACI in the live analysis

One click puts Morixe Hermanos SACI on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.